Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Anatomical and functional responses in eyes with diabetic macular edema treated with “1 + PRN” ranibizumab: one-year outcomes in population of mainland China

Fig. 2

The changes of the mean logarithm of the minimum angle of resolution (logMAR) visual acuity (VA) and central foveal thickness (CFT) during the 12-month follow-up treated with intravitreal injections of ranibizumab (IVR) under “1 + PRN” regimen. a showed that logMAR VA decreased with follow-up time-point, there were significant differences for the logMAR VA at each time-point compared with the baseline except month 1 (P > 0.05 for month 1, P < 0.05 for other follow-up time-points), (b) showed that “1 + PRN” IVR treatment significantly reduced the CFT (P < 0.05 for all time-points compared with the baseline)

Back to article page